Describing the role of ONCOS-102 in combination with aPD1 in
aPD1 refractory, advanced or unresectable melanoma
OSLO, Norway, Sept. 16, 2021 /PRNewswire/ -- Targovax
ASA (OSE: TRVX), a clinical stage immuno-oncology company
developing immune activators to target hard-to-treat solid tumors,
today announces that the poster "A pilot study of
Engineered Adenovirus ONCOS-102 in combination with pembrolizumab
(pembro) in checkpoint inhibitor refractory advanced or
unresectable melanoma" is now available at the ESMO congress
website and on the Company's website. The poster will be
presented as an e-poster at the European Society for Medical
Oncology (ESMO) congress by Dr Alexander N.
Shoushtari, Memorial Sloan Kettering Cancer Center.
The poster presents the pilot study of ONCOS-102 in combination
with pembrolizumab (pembro) in checkpoint inhibitor refractory
advanced or unresectable melanoma. The poster concludes that
co-administration of ONCOS-102 and pembrolizumab is safe and
feasible for patients with melanomas progressing on PD-1 blockade.
Rapid clinical objective responses were seen in patients treated
both sequentially and in combination, and immune markers
demonstrating induction of beneficial tumor microenvironment
changes support the role of ONCOS-102 as a complementary treatment
with aPD1 and other IO modalities.
|
E-poster
title:
|
A pilot study of
Engineered Adenovirus ONCOS-102 in combination with pembrolizumab
(pembro) in checkpoint inhibitor refractory advanced or
unresectable melanoma
|
|
E-poster
number:
|
1083P
|
|
Presenter:
|
Dr Alexander N.
Shoushtari, Memorial Sloan Kettering Cancer Center
|
Please see the poster here: Targovax ESMO 2021
poster.pdf
For further information, please contact:
Oystein Soug, CEO
Phone: +47 906 56 525
Email: oystein.soug@targovax.com
Renate Birkeli, Investor
Relations
Phone: +47 922 61 624
Email: renate.birkeli@targovax.com
Media enquires:
Andreas Tinglum - Corporate
Communications (Norway)
Phone: +47 9300 1773
Email: andreas.tinglum@corpcom.no
This information was brought to you by Cision
http://news.cision.com
https://news.cision.com/targovax/r/targovax-asa--poster-at-european-society-for-medical-oncology--esmo-,c3416046
The following files are available for download:
|
https://mb.cision.com/Public/17093/3416046/b98c3308cbc28941.pdf
|
Targovax ESMO 2021
poster
|
